{"quoteSummary":{"result":[{"defaultKeyStatistics":{"maxAge":1,"priceHint":{"raw":2,"fmt":"2","longFmt":"2"},"enterpriseValue":{"raw":15983047680,"fmt":"15.98B","longFmt":"15,983,047,680"},"forwardPE":{},"profitMargins":{"raw":0.04006,"fmt":"4.01%"},"floatShares":{"raw":220918645,"fmt":"220.92M","longFmt":"220,918,645"},"sharesOutstanding":{"raw":449825984,"fmt":"449.83M","longFmt":"449,825,984"},"sharesShort":{},"sharesShortPriorMonth":{},"sharesShortPreviousMonthDate":{},"dateShortInterest":{},"sharesPercentSharesOut":{},"heldPercentInsiders":{},"heldPercentInstitutions":{},"shortRatio":{},"shortPercentOfFloat":{},"beta":{"raw":0.115803,"fmt":"0.12"},"morningStarOverallRating":{},"morningStarRiskRating":{},"category":null,"bookValue":{"raw":4.539,"fmt":"4.54"},"priceToBook":{"raw":5.684071,"fmt":"5.68"},"annualReportExpenseRatio":{},"ytdReturn":{},"beta3Year":{},"totalAssets":{},"yield":{},"fundFamily":null,"fundInceptionDate":{},"legalType":null,"threeYearAverageReturn":{},"fiveYearAverageReturn":{},"priceToSalesTrailing12Months":{},"lastFiscalYearEnd":{"raw":1490918400,"fmt":"2017-03-31"},"nextFiscalYearEnd":{"raw":1553990400,"fmt":"2019-03-31"},"mostRecentQuarter":{"raw":1333152000,"fmt":"2012-03-31"},"earningsQuarterlyGrowth":{},"revenueQuarterlyGrowth":{},"netIncomeToCommon":{"raw":235378000,"fmt":"235.38M","longFmt":"235,378,000"},"trailingEps":{"raw":0.51,"fmt":"0.51"},"forwardEps":{},"pegRatio":{},"lastSplitFactor":"5/1","lastSplitDate":{"raw":973555200,"fmt":"2000-11-07"},"enterpriseToRevenue":{"raw":2.72,"fmt":"2.72"},"enterpriseToEbitda":{"raw":24.879,"fmt":"24.88"},"52WeekChange":{"raw":0.5356127,"fmt":"53.56%"},"SandP52WeekChange":{"raw":0.17201865,"fmt":"17.20%"},"lastDividendValue":{},"lastCapGain":{},"annualHoldingsTurnover":{}},"earnings":{"maxAge":86400,"earningsChart":{"quarterly":[]},"financialsChart":{"yearly":[{"date":2014,"revenue":{"raw":3670200000,"fmt":"3.67B","longFmt":"3,670,200,000"},"earnings":{"raw":-27700000,"fmt":"-27.7M","longFmt":"-27,700,000"}},{"date":2015,"revenue":{"raw":4014333000,"fmt":"4.01B","longFmt":"4,014,333,000"},"earnings":{"raw":21402000,"fmt":"21.4M","longFmt":"21,402,000"}},{"date":2016,"revenue":{"raw":4860976000,"fmt":"4.86B","longFmt":"4,860,976,000"},"earnings":{"raw":127997000,"fmt":"128M","longFmt":"127,997,000"}},{"date":2017,"revenue":{"raw":5875144000,"fmt":"5.88B","longFmt":"5,875,144,000"},"earnings":{"raw":235378000,"fmt":"235.38M","longFmt":"235,378,000"}}],"quarterly":[{"date":"1Q2009","revenue":{"raw":437497000,"fmt":"437.5M","longFmt":"437,497,000"},"earnings":{"raw":-7046000,"fmt":"-7.05M","longFmt":"-7,046,000"}},{"date":"1Q2010","revenue":{"raw":502481000,"fmt":"502.48M","longFmt":"502,481,000"},"earnings":{"raw":-127176000,"fmt":"-127.18M","longFmt":"-127,176,000"}},{"date":"1Q2011","revenue":{"raw":571860000,"fmt":"571.86M","longFmt":"571,860,000"},"earnings":{"raw":-111506000,"fmt":"-111.51M","longFmt":"-111,506,000"}},{"date":"1Q2012","revenue":{"raw":729200000,"fmt":"729.2M","longFmt":"729,200,000"},"earnings":{"raw":68100000,"fmt":"68.1M","longFmt":"68,100,000"}}]},"financialCurrency":"INR"},"summaryProfile":{"address1":"409, Antriksh Bhawan","address2":"4th Floor 22 Kasturba Gandhi Marg","city":"New Delhi","zip":"110001","country":"India","phone":"91 11 2332 4443","fax":"91 11 2372 2422","website":"http://www.morepen.com","industry":"Drug Manufacturers - Major","sector":"Healthcare","longBusinessSummary":"Morepen Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs), formulations, and OTC products in India, the United States, and internationally. The company offers APIs for various therapeutic areas, including anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-diabetic, and anti-hypertensive; and formulations for therapeutic classes, such as antibiotics, gastro-intestinal, CNS, ortho and pain, calcium metabolism, respiratory and anti-allergic, and nutraceuticals and vitamins, as well as diabetes and related complications, and cardiology therapy. It also provides self-health diagnostic products comprising automatic digital blood pressure monitors, digital and analog weighing scales, body and foot massagers, heat therapy range, nebulizers, pregnancy cards, clinical and digital thermometers, etc.; blood glucose monitoring systems under the GlucoOne brand name; rapid diagnostic test kits under the QuickChek brand; and hemoglobin meters, vein illumination devices, and diagnostic tests and instruments. In addition, the company offers vaporizers, pulse oximeters, hot water bottles, stethoscopes, sphygmomanometers, ultrasonic nebulizers, fetal Doppler, anti-decubitus air mattress, adult diapers, instant dry under mats, and breathable non-woven tapes. Further, it provides Dr. Morepen self-health FMHG products, including Burnol for burns and cuts; Lemolate Gold for cold relief; Fibre-X Sat-Isabgol, a natural laxative product; Fever-X, a fever reducer; Option72, an emergency contraceptive; Dabgel, an antacid; MoreVital+, a dietary supplement; Exygra, a sildenafil citrate; QuickChek, a pregnancy card; and other products. Additionally, the company is involved in product contract manufacturing and brand sharing businesses. Morepen Laboratories Limited was founded in 1984 and is headquartered in New Delhi, India.","companyOfficers":[],"maxAge":86400},"financialData":{"maxAge":86400,"currentPrice":{"raw":25.8,"fmt":"25.80"},"targetHighPrice":{},"targetLowPrice":{},"targetMeanPrice":{},"targetMedianPrice":{},"recommendationMean":{"raw":2.0,"fmt":"2.00"},"recommendationKey":"buy","numberOfAnalystOpinions":{},"totalCash":{"raw":45100000,"fmt":"45.1M","longFmt":"45,100,000"},"totalCashPerShare":{"raw":0.1,"fmt":"0.1"},"ebitda":{"raw":642440000,"fmt":"642.44M","longFmt":"642,440,000"},"totalDebt":{"raw":1138899968,"fmt":"1.14B","longFmt":"1,138,899,968"},"quickRatio":{"raw":0.531,"fmt":"0.53"},"currentRatio":{"raw":0.974,"fmt":"0.97"},"totalRevenue":{"raw":5875144192,"fmt":"5.88B","longFmt":"5,875,144,192"},"debtToEquity":{"raw":35.593,"fmt":"35.59"},"revenuePerShare":{"raw":13.061,"fmt":"13.06"},"returnOnAssets":{"raw":0.03603,"fmt":"3.60%"},"returnOnEquity":{"raw":0.07557,"fmt":"7.56%"},"grossProfits":{"raw":2206439000,"fmt":"2.21B","longFmt":"2,206,439,000"},"freeCashflow":{"raw":141694368,"fmt":"141.69M","longFmt":"141,694,368"},"operatingCashflow":{"raw":635123968,"fmt":"635.12M","longFmt":"635,123,968"},"earningsGrowth":{},"revenueGrowth":{"raw":0.275,"fmt":"27.50%"},"grossMargins":{"raw":0.37555,"fmt":"37.56%"},"ebitdaMargins":{"raw":0.10935,"fmt":"10.94%"},"operatingMargins":{"raw":0.0521,"fmt":"5.21%"},"profitMargins":{"raw":0.04006,"fmt":"4.01%"},"financialCurrency":"INR"}}],"error":null}}